ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      58,032.51
      2.44%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      02/16/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/12/20218:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/21/20216:05PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/14/20218:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/14/20218:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart FailureNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/11/202110:52AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/06/20218:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/05/20215:28PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/01/20211:40AMTipRanksLexicon Pharma Kicks Off Dosing In Phase 2 Study Of Post-Herpetic Neuralgia TreatmentNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/31/20208:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic NeuralgiaNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/21/20204:37PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/18/20204:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/17/20202:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/17/20202:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/16/20204:05PMGlobeNewswire Inc.Lexicon Pharmaceuticals Enters Data Collaboration With AC BioscienceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/11/20205:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/11/20208:01AMGlobeNewswire Inc.Lexicon Announces Offering of Common StockNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/11/20207:37AMGlobeNewswire Inc.Lexicon Pharmaceuticals Receives Fast Track Designation From the FDA for LX9211 for Diabetic Peripheral Neuropathic PainNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/17/20207:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/16/202010:01PMGlobeNewswire Inc.Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Sci...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/16/20208:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/30/20205:11PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/29/20206:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/27/20208:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Third Quarter 2020 Financial Results Conference Call and Webcast on October 29, 2020NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/29/20207:14AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/24/20207:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/23/20206:43PMGlobeNewswire Inc.Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding IndebtednessNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/11/20204:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/08/20205:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/08/20204:05PMGlobeNewswire Inc.Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera TherapeuticsNASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX